FDA signs off on Alzheimer’s drug patch
Contemporary Long-Term Care Weekly, July 12, 2007
The U.S. Food and Drug Administration (FDA) approved the first skin patch for treatment of Alzheimer's disease, according to CNN.com. The patch will be developed by Novartis Pharmaceuticals Corp. and contain the drug Exelon (rivastigimine), used presently in capsule form to treat mild dementia symptoms associated with Alzheimer's. The patch will provide patients with a continuous dose of the drug throughout the day, without the stomach pains that afflict many patients taking the oral version, CNN.com reported. The FDA also approved Novartis' patch for use with Parkinson's disease patients.
Related Products
-
PPS Alert for Long-Term Care
Looking for a tool to make your job easier? PPS Alert for Long-Term Care, exclusively for the RN or MDS coordinator, is your...
-
Billing Alert for Long-Term Care
It's essential to know how to correctly submit your Medicare claims in order to get the reimbursement your facility...
-
CNA Training Advisor: Lesson Plans for Busy Staff Trainers
Finally-a staff training program that really works!
-
MDS 3.0 Update
HCPro's MDS 3.0 Update is a free bi-weekly e-newsletter that provides MDS coordinators and skilled nursing facility staff...
-
The Long-Term Care Nursing Assistant's Guide to Advanced Restorative Skills
This book is written specifically for RNAs or nursing assistants to help them provide quality restorative care. Author...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Catch up on what's new with injections and infusions
- Case Management Monthly, June 2012
- Searched